SPRIM Global Investments is a New York-based venture capital firm investing in clinical-stage life sciences and pharma services companies across Europe, Asia-Pacific, the Americas and France. It focuses on biotechnology, medical devices, medtech, healthcare IT, digital health, pharmaceuticals and oncology, backing Series A and growth-stage equity opportunities and providing non-dilutive credit for clinical-stage companies.